Corbus Pharmaceuticals Inc.
CRBP | NASDAQ
$7.68
+$0.03 (+0.39%)
Sep 22, 2026, 12:07 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -1.38 | -3.21 | -0.59 | -0.33 | -1.66 | -0.88 |
PEG Ratio | -0.02 | 0.05 | -0.37 | 0.04 | 0.02 | -0.03 |
PS Ratio | n/a | n/a | n/a | n/a | 85.93 | 24.81 |
PB Ratio | 0.73 | 0.90 | -3.78 | 0.42 | 1.10 | 2.16 |
P/FCF Ratio | -1.68 | -3.08 | -0.72 | -0.37 | -1.57 | -0.98 |
P/OCF Ratio | -1.68 | -3.08 | -0.72 | -0.37 | -1.57 | -0.98 |
OCF/S Ratio | n/a | n/a | n/a | n/a | -5.46K | -2.53K |
Debt / Equity Ratio | 0.01 | 0.02 | -3.02 | 0.76 | 0.38 | 0.59 |
Quick Ratio | 8.07 | 12.94 | 0.74 | 4.76 | 5.89 | 2.88 |
Current Ratio | 8.07 | 12.94 | 0.74 | 4.76 | 5.89 | 2.89 |
Asset Turnover | n/a | n/a | n/a | n/a | 0.01 | 0.04 |
Interest Coverage | n/a | -26.03 | -15.42 | -16.34 | -30.59 | -119.42 |
Return on Equity | -53.24% | -28.23% | 645.97% | -169.24% | -65.92% | -245.76% |
Return on Assets | -46.69% | -25.80% | -157.77% | -84.20% | -42.28% | -108.77% |
Return on Invested Capital | -57.20% | -33.45% | -321.43% | -59.96% | -58.49% | -170.31% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | -85.92% | 100% |
Net Profit Margin | n/a | n/a | n/a | n/a | -5.17K% | -2.83K% |
Pretax Profit Margin | n/a | n/a | n/a | n/a | -5.18K% | -2.83K% |
Operating Profit Margin | n/a | n/a | n/a | n/a | -6.35K% | -3.12K% |
FCF Margin | n/a | n/a | n/a | n/a | -5.47K% | -2.54K% |
EBITDA Margin | n/a | n/a | n/a | n/a | -4.78K% | -3.08K% |
Add to Watchlist
Select watchlists to add or remove CRBP